Exact Mass: 560.3865392
Exact Mass Matches: 560.3865392
Found 316 metabolites which its exact mass value is equals to given mass value 560.3865392,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2-Hexaprenyl-3-methyl-6-methoxy-1,4 benzoquinone
2-Hexaprenyl-3-methyl-6-methoxy-1,4 benzoquinone is involved in the ubiquinone biosynthesis pathway. 2-Hexaprenyl-3-methyl-6-methoxy-1,4 benzoquinone is created from 2-Hexaprenyl-6-methoxy-1,4-benzoquinone by ubiquinone biosynthesis methyltransferase [EC:2.1.1.-]. 2-Hexaprenyl-3-methyl-6-methoxy-1,4 benzoquinone is then converted to 2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone by ubiquinone biosynthesis monooxygenase Coq7 [EC:1.14.13.-]. [HMDB] 2-Hexaprenyl-3-methyl-6-methoxy-1,4 benzoquinone is involved in the ubiquinone biosynthesis pathway. 2-Hexaprenyl-3-methyl-6-methoxy-1,4 benzoquinone is created from 2-Hexaprenyl-6-methoxy-1,4-benzoquinone by ubiquinone biosynthesis methyltransferase [EC:2.1.1.-]. 2-Hexaprenyl-3-methyl-6-methoxy-1,4 benzoquinone is then converted to 2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone by ubiquinone biosynthesis monooxygenase Coq7 [EC:1.14.13.-].
Deferoxamine
Deferoxamine is only found in individuals that have used or taken this drug. It is a natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. [PubChem]Deferoxamine works in treating iron toxicity by binding trivalent (ferric) iron (for which it has a strong affinity), forming ferrioxamine, a stable complex which is eliminated via the kidneys. 100 mg of deferoxamine is capable of binding approximately 8.5 mg of trivalent (ferric) iron. Deferoxamine works in treating aluminum toxicity by binding to tissue-bound aluminum to form aluminoxamine, a stable, water-soluble complex. The formation of aluminoxamine increases blood concentrations of aluminum, resulting in an increased concentration gradient between the blood and dialysate, boosting the removal of aluminum during dialysis. 100 mg of deferoxamine is capable of binding approximately 4.1 mg of aluminum. V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AC - Iron chelating agents D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Deferoxamine (Deferoxamine B) is an iron chelator (binds to Fe(III) and many other metal cations), is widely used to reduce iron accumulation and deposition in tissues. Deferoxamine upregulates HIF-1α levels with good antioxidant activity. Deferoxamine also shows anti-proliferative activity, can induce apoptosis and autophagy in cancer cells. Deferoxamine can be used in studies of diabetes, neurodegenerative diseases as well as anti-cancer and anti-COVID-19[1][2][3][4][5].
Vitamin D3 glucosiduronate
DG(8:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)
DG(8:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/8:0/0:0)
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))
DG(8:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/8:0)
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)
DG(8:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/8:0/0:0)
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))
DG(8:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/8:0)
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Basilol
Basilol is a member of the class of compounds known as triterpenoids. Triterpenoids are terpene molecules containing six isoprene units. Basilol is practically insoluble (in water) and an extremely weak acidic compound (based on its pKa). Basilol can be found in sweet basil, which makes basilol a potential biomarker for the consumption of this food product.
3-O-beta-D-glucosyl-brassicasterol
3-o-beta-d-glucosyl-brassicasterol is a member of the class of compounds known as steroidal glycosides. Steroidal glycosides are sterol lipids containing a carbohydrate moiety glycosidically linked to the steroid skeleton. 3-o-beta-d-glucosyl-brassicasterol is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 3-o-beta-d-glucosyl-brassicasterol can be found in a number of food items such as salmonberry, abalone, roman camomile, and canola, which makes 3-o-beta-d-glucosyl-brassicasterol a potential biomarker for the consumption of these food products.
Oleoyl danshenxinkun A
A diterpenoid with a fatty acyl side chain isolated from Salvia miltiorrhiza and has been shown to inhibit platelet aggregation induced by arachidonic acid.
2, 16, 18-Tri-Ac-(1alpha, 3beta, 11alpha)-Cholest-5-ene-2, 3, 16, 18-tetrol, 9CI
Ecdysterone 2,3:20,22-diacetonide
Origin: Plant; SubCategory_DNP: The sterols, Cholestanes
22E,24R-ergosta-7,22-dien-3-O-beta-glucopyranoside|ergosta-7,22-dien-3-O-beta-D-glucopyranoside
7, 15, 18-Tri-Ac-(3alpha, 7beta, 15beta)-Cholest-5-ene-3, 7, 15, 18-tetrol, 9CI
(-)-6-dehydroxy-O10-buxafuranamine|6-Dehyroxy-O10-buxafuranamine
24-methylenecholest-5-en-3beta,16beta-diol-3-O-alpha-L-fucopyranoside|24-methylenecholest-5-en-3beta,16beta-diol-3-O-alpha-L-fucoside|24-methylenecholest-5-ene-3beta,16beta-diol-3-O-alpha-L-fucopyranoside
12alpha-acetoxy-16beta-(3-hydroxybutanoyloxy)-13beta,18beta-cyclobutan-20,24-dimethyl-24-oxoscalaran-25-ol
3alpha-hydroxy-13alpha-ursan-28,12beta-olide 3-benzoate
O-alpha-D-Riburonofuranoside-Stigmast-5-en-3-ol|O-alpha-D-Xyluronofuranoside-Stigmast-5-en-3-ol|O-beta-D-Xyluronofuranoside-Stigmast-5-en-3-ol
(E)-3beta-hydroxy-15beta-O-(beta-D-xylopyranosyl)-ergosta-5,22-dien-16-one|acanthifolioside A
3beta-O-beta-D-glucopyranosyl-24-methylenecholesterol
(8S)-8-(6-O-acetyl-b-D-glucopyranosyloxy)docosanoic acid
3-O-methylmalonylepiocotillol II|3-O-methylmalonylepiocotillol-II
(6S)-6-(6-O-acetyl-b-D-glucopyranosyloxy)docosanoic acid
24-O-butyl-2alpha,3beta,19alpha,24-tetrahydroxyurs-12-ene-28-oic acid
7alpha-acetoxy-21R?,23R?-epoxy-24S?,25-dihydroxy-21alpha-methoxy-4,4,8-trimethyl-cholesta-14-en-3-one|7alpha-acetoxy-21S?,23R?-epoxy-24S?,25-dihydroxy-21beta-methoxy-4,4,8-trimethyl-cholesta-14-en-3-one|brujavanone I|brujavanone J
24-epi-pterosterone 2,3:20,22-diacetonide|24-epipterosterone-2,3,20,22-diacetonide
ajugasterone C 2,3;20,22-diacetonide|ajugasterone C-2,3,20,22-diacetonide
3beta-benzoyl-D:A-friedo-oleanan-27,16alpha-lactone
12alpha-acetoxy-16beta-(3R-hydroxybutanoyloxy)-20,24-dimethyl-24-oxoscalaran-25-al
3alpha,12beta-diacetoxy-20(S),24(R)-epoxy-25-hydroxydammarane|3alpha,12beta-diacetoxy-25-hydroxy-20S,24R-epoxydammarane|3alpha-,12beta-diacetoxy-20(S),24(R)-epoxydammaran-25-ol
3alpha,22alpha-diacetoxy-20beta,21alpha,29-trihydrohy-30-norolean-12-ene
deferoxamine
V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AC - Iron chelating agents D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Deferoxamine (Deferoxamine B) is an iron chelator (binds to Fe(III) and many other metal cations), is widely used to reduce iron accumulation and deposition in tissues. Deferoxamine upregulates HIF-1α levels with good antioxidant activity. Deferoxamine also shows anti-proliferative activity, can induce apoptosis and autophagy in cancer cells. Deferoxamine can be used in studies of diabetes, neurodegenerative diseases as well as anti-cancer and anti-COVID-19[1][2][3][4][5].
N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxybutanediamide
Desferrioxamine b
An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
3-O-alpha-L-rhamnopyranosyl-3-hydroxymyristoyl-3-hydroxydecanoic acid
4,4-Bis[(1E)-2-[4-(hexyloxy)phenyl]ethenyl]-2,2-bipyridine
dodecane-1-thiol,2-methylidenebutanoic acid,methyl 2-methylprop-2-enoate,2-methylprop-2-enoic acid,prop-2-enoic acid
7-Demethoxyegonol Oleate
A fatty acid ester that is egonol oleate in which the methoxy group at position 7 is replaced by a hydrogen. Isolated from the fruits of Styrax agrestis, it exhibits inhibitory activity against acetylcholinesterase.
3-O-beta-D-glucosyl-brassicasterol
3-o-beta-d-glucosyl-brassicasterol is a member of the class of compounds known as steroidal glycosides. Steroidal glycosides are sterol lipids containing a carbohydrate moiety glycosidically linked to the steroid skeleton. 3-o-beta-d-glucosyl-brassicasterol is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 3-o-beta-d-glucosyl-brassicasterol can be found in a number of food items such as salmonberry, abalone, roman camomile, and canola, which makes 3-o-beta-d-glucosyl-brassicasterol a potential biomarker for the consumption of these food products. 3-o-β-d-glucosyl-brassicasterol is a member of the class of compounds known as steroidal glycosides. Steroidal glycosides are sterol lipids containing a carbohydrate moiety glycosidically linked to the steroid skeleton. 3-o-β-d-glucosyl-brassicasterol is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 3-o-β-d-glucosyl-brassicasterol can be found in a number of food items such as salmonberry, abalone, roman camomile, and canola, which makes 3-o-β-d-glucosyl-brassicasterol a potential biomarker for the consumption of these food products.
(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-6-[[(1S,2S,7S,10R,11S,14S,15R,16S,17R,20S,23S)-10,14,16,20-tetramethyl-22-azoniahexacyclo[12.10.0.02,11.05,10.015,23.017,22]tetracos-4-en-7-yl]oxy]oxane-3,4,5-triol
C33H54NO6+ (560.3950924000001)
Cholcalciferyl-β-D-glucopyranosid-uronsaeure
DG(8:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/8:0/0:0)
DG(8:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/8:0)
DG(8:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/8:0/0:0)
DG(8:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/8:0)
24-methylenecholesteryl beta-D-glucoside
A sterol 3-beta-D-glucoside having 24-methylenecholesterol as the sterol component.
3-cyclohexyl-1-[[(3R,9R,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(3R,9S,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(3S,9S,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(3S,9R,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(3R,9R,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(3S,9S,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(3S,9S,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(3R,9R,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(3R,9R,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(3S,9R,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(3R,9S,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(3S,9S,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methylurea
(2S)-2,6-bis[[(3R)-3-isocyanododecanoyl]amino]hexanoic acid
[(4E,8E)-3-hydroxy-2-(pentanoylamino)nonadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C29H57N2O6P (560.3954031999999)
[(4E,8E)-3-hydroxy-2-(propanoylamino)henicosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C29H57N2O6P (560.3954031999999)
[(4E,8E)-2-(butanoylamino)-3-hydroxyicosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C29H57N2O6P (560.3954031999999)
[(4E,8E)-3-hydroxy-2-(octanoylamino)hexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C29H57N2O6P (560.3954031999999)
[(4E,8E)-3-hydroxy-2-(nonanoylamino)pentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C29H57N2O6P (560.3954031999999)
[(4E,8E)-2-(heptanoylamino)-3-hydroxyheptadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C29H57N2O6P (560.3954031999999)
[(E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C29H57N2O6P (560.3954031999999)
[(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]non-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C29H57N2O6P (560.3954031999999)
[(4E,8E)-2-acetamido-3-hydroxydocosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C29H57N2O6P (560.3954031999999)
[(4E,8E)-2-(hexanoylamino)-3-hydroxyoctadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C29H57N2O6P (560.3954031999999)
[(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]undec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C29H57N2O6P (560.3954031999999)
[(4E,8E)-2-(dodecanoylamino)-3-hydroxydodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C29H57N2O6P (560.3954031999999)
[(4E,8E)-2-(decanoylamino)-3-hydroxytetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C29H57N2O6P (560.3954031999999)
[(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
C29H57N2O6P (560.3954031999999)
[(4E,8E)-3-hydroxy-2-(undecanoylamino)trideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C29H57N2O6P (560.3954031999999)
[1-acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-octadec-9-enoate
[1-butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-hexadec-9-enoate
[1-propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-heptadec-9-enoate
[1-hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-tetradec-9-enoate
[1-heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-tridec-9-enoate
[1-pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-pentadec-9-enoate
[2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxyoctyl] 2-(trimethylazaniumyl)ethyl phosphate
C29H57N2O6P (560.3954031999999)
(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate
(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate
(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate
(1-octanoyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate
(1-hexanoyloxy-3-phosphonooxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate
(1-butanoyloxy-3-phosphonooxypropan-2-yl) (13Z,16Z)-docosa-13,16-dienoate
(1-acetyloxy-3-phosphonooxypropan-2-yl) (13Z,16Z)-tetracosa-13,16-dienoate
(1-decanoyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate
[3-phosphonooxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-tridec-9-enoate
[1-carboxy-3-[2-hydroxy-3-[(5E,8E,11E,14E,17E,20E)-tricosa-5,8,11,14,17,20-hexaenoyl]oxypropoxy]propyl]-trimethylazanium
C33H54NO6+ (560.3950924000001)
(1-decanoyloxy-3-phosphonooxypropan-2-yl) (4E,7E)-hexadeca-4,7-dienoate
[(2S,3R,4E,8E)-2-(decanoylamino)-3-hydroxytetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C29H57N2O6P (560.3954031999999)
[(2S,3R,4E,6E)-2-(decanoylamino)-3-hydroxytetradeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
C29H57N2O6P (560.3954031999999)
2-[hydroxy-[3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]-2-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[Carboxy-(2-dodecanoyloxy-3-octanoyloxypropoxy)methoxy]ethyl-trimethylazanium
2-[Carboxy-(3-nonanoyloxy-2-undecanoyloxypropoxy)methoxy]ethyl-trimethylazanium
2-[Carboxy-[2,3-di(decanoyloxy)propoxy]methoxy]ethyl-trimethylazanium
2-[[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
TG(31:4)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved